Skip to main content
OpenTrials
Completed

NCT Number: NCT05698069

Turkish Version of Pain Modulation Index

In order to assess the validity and reliability of the Turkish version of Pain Modulation Index, 125 volunteers with chronic pain were enrolled in the study. Test and re-test method was used to assess reliability and correlation analyses with Pain Detect, visual analog scale pain and central sensitization inventory scores were used to assess validity of the questionnaire. Turkish version of the Pain Modulation Index was found to be a valid and reliable tool for evaluating chronic pain.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Ege University Hospital, Department of Physical and rehabilitation medicine

Bornova, İzmir, 355100, Turkey (Türkiye)

About this study

Pain Modulation Index is a questionnaire that was developed in English for the assessment of chronic pain for qualities consistent with central sensitization. The English version of the questionnaire was translated into Turkish by two physicians than back translated into English by two separate bilingual translators. Initially 10 volunteers were asked to answer this first version of the questionnaire and report any difficulties in understanding the items. Their feedback was used to give the questionnaire its final shape. For the validation stage, patients that were diagnosed as having chronic non-cancer pain with more than 3 months duration were enrolled into the study. They answered the questions twice, 15 days apart. In addition to the Turkish version of the Pain Modulation Index, on the first visit, they were also asked to answer Pain Detect and Central Sensitization Inventory. Their answers were analysed to assess the validity and reliability of the Turkish version of Pain Modulation Index.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • presence of chronic non-cancer pain of more than 3 months duration

Exclusion criteria

  • Illiteracy
  • Refusal to take part in the study

Treatment and study plan

Pain Modulation Index

Diagnostic Test

A 18 item questionnaire assessing patients' pain characteristics for the detection of disordered pain modulation processes.

Pain Detect

Other

A questionnaire that was validated for the assessment of neuropathic pain

Central sensitization inventory

Other

A questionnaire developed for the detection of central sensitization.

Primary outcomes

  1. Reliability of the Turkish version of pain modulation index

    Time frame: 15 days

    Internal consistency was evaluated by test retest method and calculating the coefficient alpha (α) or Cronbach's coefficient, and if the Cronbach's coefficient value was greater than 0.7, it was considered as an acceptable internal consistency

  2. Validity of the Turkish version of Pain Modulation Index

    Time frame: 1 day

    Index scores were analysed for their correlation with Pain Detect and Central Sensitization Inventory scores.

Sponsors and collaborators

Lead sponsor

Ege University

Other

Registry information

Official study title

Reliability and Validity of the Turkish Version of the Pain Modulation Index

Important dates

Study start
2022
Primary completion
2022
Study completion
2023
First posted
Jan 26, 2023
Registry last updated
Jan 26, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.